A b s t r a c t
The diagnosis of large cell lymphoma by flow cytometric analysis often is difficult, as reported in the literature and in hospital practice. Up to 15% of lymphomas may show normal flow cytometric results, which is more common in cases of large cell (up to 25%) and Hodgkin lymphoma. [1] [2] [3] Some investigators have identified monoclonality in only 69% of cytologically low-grade and 35% of high-grade lymphomas. 4 The pitfalls of immunophenotyping for any lymphoma include inaccurate sampling, lack of uniform involvement of the tissue sample by lymphoma, and inadequate sample size. [5] [6] [7] Suggested explanations of nondiagnostic flow cytometric results that are specific to large cell lymphomas include frequent cell apoptosis, cell fragility, and necrosis. [5] [6] [7] [8] Apoptotic cells may be found in the low forward and side scatter region and, therefore, be discounted mistakenly, without further analysis, as uninformative cellular debris. 9, 10 Cell fragility and necrosis often lead to underrepresentation of neoplastic cells in a biopsy or aspiration specimen. 8 In one analysis, cytologic preparations for flow cytometry showed 46% viability in 10 cases of low-grade and only 25% viability in 11 cases of aggressive B-cell lymphomas. 11 Sclerosis also is found more commonly in large cell lymphomas, especially those in the mediastinum. 12 Sclerosis may lead to cell distortion on fine-needle aspiration (FNA) and biopsy, as well as unexpected flow cytometric scatter characteristics. These lymphomas also may be difficult to aspirate, yielding cell damage, cellular debris, and nonviable cells that make gating and immunophenotyping of these cells difficult. 13 cell lymphomas were compared to identify whether they correlated with unusual flow cytometric patterns. Our hypothesis was that flow cytometric analysis is more commonly nondiagnostic or more difficult to analyze in cases with greater degrees of apoptosis, necrosis, and cellular pleomorphism.
Materials and Methods

Case Selection
A computer-based search of the flow cytometry files at Evanston and Glenbrook hospitals (Evanston, IL, and Glenbrook, IL) of cases between January 1, 1995, and July 30, 1999 , identified 63 cases of large B-cell lymphoma in which flow cytometric analysis was used in the diagnostic workup. These cases were extracted from a total of 1,412 samples submitted for flow cytometric workup of leukemias or lymphomas in the same time period, therefore representing 4.5% of our database. In 5 of these cases, the original diagnostic slides were unavailable for review. Of the 58 cases available for review, 7 were eliminated owing to inadequate histologic or cytologic material to assess all parameters of interest. Of the remaining 51 cases, 21 were from material obtained from FNA, 1 from pleural fluid submitted for cytology, 4 from bone marrow biopsies, and 25 from surgical specimens. If more than one specimen was submitted for flow cytometric analysis, for example, for staging, the initial specimen was used. No patients had received treatment with anti-CD20 antibodies. The gating patterns, percentage of atypical cells, and immunophenotypes for these 51 cases were reviewed to correlate with the histologic findings. Institutional review board exempt status was obtained for the study protocol.
Morphologic Examination
The surgical pathology and bone marrow core biopsy slides were obtained from tissue fixed with 10% buffered formalin, embedded with paraffin, and stained with routine H&E. The FNA material was manually smeared or processed by Cytospin of tissue fluid for staining by Giemsa and/or Papanicolaou techniques. All slides were reviewed by a pathologist board-certified in hematology (M.A.M.). The diagnostic lymphoma cells were large cells with nuclei at least twice the size of a small lymphocyte, with vesicular chromatin and prominent nucleoli, and basophilic cytoplasm. 14 The following features were recorded: nodal vs extranodal; diffuse vs follicular; percentage of large atypical cells (>75%, 25%-75%, or <25%); presence of sclerosis, focal or geographic necrosis, hemorrhage, acute inflammation, and extracapsular extension; degree of apoptosis and pleomorphism; mitoses per 10 high-power fields (HPF); and immunohistochemical staining results, if done.
In some cases, the classification of the site of biopsy as nodal or extranodal was unclear. The surgeon's impression, as recorded on the specimen requisition, that a nodule or mass was a lymph node was not assumed to be always correct. Many biopsy specimens included tissues with predominantly lymphoid cells, including lymphoma cells with or without concomitant benign-appearing small lymphocytes. Nodal was defined as having the criteria of a recognizable fibrous capsule, subcapsular sinus, sinus histiocytes, and residual germinal centers. Depending on the extent of involvement by the neoplastic cells, not all of these features were seen on every slide of the biopsy specimen, but all were present at least focally.
Only biopsy specimens and bone marrow cores were subjected to mitotic counts. Criteria for classification of mitotic figures (vs pyknotic nuclei or other artifacts) included those previously published and cited by others including the following: (1) lack of nuclear membrane; (2) basophilia of surrounding cytoplasm (vs dense eosinophilia); (3) presence of delicate nuclear projections of condensed chromosomes clotted (beginning metaphase), in a plane (metaphase/anaphase), or separate aggregates (telophase); (4) adequately thinly cut (4 µm) and stained histologic preparations; and (5) exclusion of doubtful figures. [15] [16] [17] Mitotic counts were started at the areas where the number of mitoses were highest, with random contiguous fields used to complete the analysis of 10 HPF (×400). 15 Fields with necrosis or less than 50% tumor cells were avoided. The same microscope was used for mitotic counts on all cases.
Apoptosis was quantified as + or ++. Slides with "+" had occasional scattered apoptotic cells, compared with abundant and throughout most fields in "++" cases. Pleomorphism was graded as mild or marked based on variability of nuclear size and irregularity of nuclear outlines. Other features also were recorded on a case-by-case basis, for example, presence of epithelioid histiocytes or spindled cells.
Flow Cytometric Analysis
Solid tissue samples before February 1998 (16 of 51) were minced with scissors to create a cell suspension. Subsequent samples were prepared using Medicon capsules (pore size 50 µm) and Medimachine tissue disaggregator (Consul T.S., Torino, Italy). The tissue was added to the Medicon capsule with 1 mL of phosphate-buffered saline, and disaggregated for 15 seconds if a lymph node and 40 seconds if skin or other dense tissue.
All cases were evaluated by 3-color flow cytometric analysis using the Coulter Epics XL-MCL (Miami, FL). Clinical information or morphologic input from the pathologists involved in the case led to initial tailoring of antibody panels to evaluate for lymphoma and to look for specific types, as recommended by others. 6 Morphologic information included neoplastic cell size (large, small, pleomorphic) and architecture (follicular vs diffuse). In the cases submitted for this review, the following 5-tube initial antibody combinations were used: CD45 ( Initial gating strategies involved isolation of lymphocytes based on light scatter characteristics and CD45 density. In general, a gate was drawn to include the populations of cells with lowest side scatter, followed by selection of CD45+ cells. Secondary gating concentrated on separating cells with higher forward scatter (larger cells) or lower side scatter (apoptotic cells) than normal small lymphocytes. 9, 10 Although most histograms for each tube were generated from the cells with higher forward scatter, the initial gate drawn around the population of low side and forward scatter also was analyzed. In many cases, flow cytometric analysis was replayed using different gating strategies to identify small populations of neoplastic cells. A log scale was used in 1 case to further characterize a neoplastic cell population (see "Discussion").
Intensity of antibody staining was defined as follows: dim, overlap with isotypic control; moderate, distinct population from isotypic control; or bright, 2-log above isotypic control population.
Determination of monoclonality was based on combining the histogram pattern and percentage of cell positivity for the tested antigens. An abnormal kappa/lambda ratio was defined as outside the range of 1.0 to 3.0 for bone marrow aspirates and 1.0 to 2.0 for all other specimens. In our flow cytometry interpretations, a kappa/lambda ratio outside these ranges, combined with other antigen expression patterns, generally prompts closer investigation for a neoplastic clonal population.
Statistical Analysis
Statistical analysis was performed using SAS (Statistical Analysis Software, Cary, NC) with the chi-square and analysis of variance formulas. A P less than .05 was used to reject the null hypothesis that the measured demographic value or histologic feature varied independently of immunophenotype.
Results
Demographics
Of the study subjects, 27 (53%) were women and 24 (47%) were men (male/female ratio, 0.89); the average age was 70 years (range, 31-93 years) ❚Table 1❚. There was no statistically significant relationship between lymphoma morphologic features or immunophenotype and these demographic variables.
Histologic Correlation
Mitoses ranged from 1 to 94 per 10 HPF, with an average of 29. Twenty-two cases could not be submitted for mitotic count because fewer than 10 fields were adequate for counting or the tissue submitted was an aspirate. Of the cases, 28 (55%) were nodal, 22 (43%) were extranodal, and 1 case (2%) could not be evaluated for nodal architecture. High cellularity of neoplastic cells was seen in 30 samples (59%), moderate cellularity in 15 (29%), and low cellularity in 4 (8%), and 2 cases (4%) could not be evaluated for this feature owing to low overall cellularity of the sample. Apoptosis was abundant in 13 cases (25%), present in 32 cases (63%), absent in 3 cases (6%), and not evaluated in 3 cases (6%) owing to low overall cellularity. Sclerosis was observed in 7 cases (14%). Geographic areas of necrosis were found in 6 cases (12%). Table 1 gives these data for each case. None of these variables showed a statistically significant relationship with immunophenotype or flow cytometric pattern.
Immunophenotyping
Four cases (8%) failed to show monoclonality by flow cytometric analysis; the samples showed polyclonal, immunophenotypically normal B cells with or without normal or reactive T cells. ❚Table 2❚ illustrates the staining intensity of CD45, CD19, and CD20, and light chain type and intensity for the 47 cases with positive flow cytometry. These remaining 47 cases also contributed to the summarized data in ❚Table 3❚ and ❚Table 4❚.
Five distinct patterns were identified when reviewing the flow cytometric data: (1) The data were analyzed as a whole, within each of the 5 groups, and by combining groups 2 through 4 as complex cases to compare with the classic cases of group 1. Correlations were sought with age of patient; type of specimen (surgical, cytology, or bone marrow); site as nodal or extranodal; cellularity of malignant cells; presence of necrosis and sclerosis; degree of apoptosis; number of mitoses; kappa or lambda monoclonality; and CD45, CD19, and CD20 positivity and intensity. Forty-one percent of clear-cut cases (7/17) by flow cytometric analysis were extranodal, compared with 44% of the complex cases (15/34). Clear-cut cases were more mitotically active (average of 42 vs 25 per 10 HPF) and contained higher cellularity of malignant cells. Significant apoptosis was seen by morphologic examination in most cases, but its degree did not predict which cases would be more challenging to diagnose by flow cytometric analysis. Complex flow cytometric results were seen in 86% of cases (6/7) with sclerosis and in 67% of cases (4/6) with geographic necrosis identified microscopically, but no statistically significant relationship was calculated. Dim expression of CD20 was more prevalent in the complex flow cytometric cases (P = .03). Otherwise, antigen distribution did not seem to be different between the groups. Monoclonal expression of kappa was identified in 74% of cases overall, compared with 21% lambda, but the difference between groups was similar (82% kappa/18% lambda in classic cases and 77% kappa/23% lambda in the complex category). Nearly all cases showed kappa/lambda ratios far outside the thresholds detailed in the "Material and Methods" section. The median kappa/lambda ratio was 72.00 for samples with kappa expression and .07 for those expressing lambda light chain. 
Discussion
In our experience, the discordance between morphologic features and immunophenotyping results for large cell lymphomas remains problematic. Necrosis, apoptosis, and/or high mitotic activity reflecting high cell turnover were features common to nearly all cases of large cell lymphoma to varying degrees in our study, with no statistical correlation to flow cytometric results. An unexpected finding was a higher mitotic rate among the clear-cut cases with classic flow cytometric patterns and morphologic features. This may be reflected by the overall higher average cellularity of lymphoma cells per case in this group. Sclerosis has been reported to prevent optimal sampling of lymphomas and lead to fragmentation and distortion of diagnostic cells, and as expected, sclerosis was more frequent in cases with complex flow cytometric results. 13 Complex cases were more likely to be extranodal. A possible explanation is that these sites are less populated with diagnostic cells than a lymph node is, typically the primary site of the malignant neoplasm. However, 59% of the extranodal samples (13/22) contained more than 75% cellularity of malignant cells, as did 54% of the nodal samples (15/28). Nevertheless, extranodal samples more often represented the least cellular tier: 14% of extranodal samples (3/22) contained fewer than 25% diagnostic cells, compared with 4% of nodal cases (1/28). Extranodal lymphomas also might be construed as being of higher grade, therefore showing features associated with high-grade tumors, including necrosis and high mitotic activity. Extranodal cases, however, featured an average of 25 mitoses per 10 HPF (range, 1-65), while nodal cases averaged 31 mitoses per 10 HPF (range, 4-94). Geographic necrosis was found in 9% of extranodal cases (2/22) and in 14% of nodal cases (4/28). One expected trend that was confirmed by our data was the frequent presence of sclerosis in extranodal cases involving dense tissues such as skin and the abdominal wall. As previously mentioned, sclerosis may affect cell viability and structural integrity during biopsy, with potential impact on flow cytometric results.
In the process of reviewing the flow cytometric results, we were able to identify valuable tools to help the flow cytometrist improve false-negative or nondiagnostic rates in the workup of large B-cell lymphomas. Among the potential pitfalls are the presence of neoplastic cells within the low side and forward scatter and high side scatter regions, often discounted as "dead" cells or granulocytes, respectively. The US-Canadian consensus has recommended that initial gating be based on viable cells, which can be selected based on viability staining or exclusion of events in the lowest forward and side scatter regions. 18 Others exclude from analysis cells that appear to be granulocytes based on high side scatter. 19 Our case review showed that in many cases, nonviable-appearing cells as judged by light scatter characteristics and cells with higher than expected side scatter were the only diagnostic cells or showed the same phenotype as larger, hypogranular classicappearing lymphoma cells also present in the sample. It is therefore important to evaluate these regions for diagnostic cells before labeling them as cell debris or nonlymphocytes. Other cases showed no clear separation between normal and neoplastic cells based on light scatter. In one such case, a log side scatter vs forward scatter plot was useful as a gating strategy to help delineate the neoplastic population from benign cells that were similar in size. Samples also may contain a mixture of large and small neoplastic lymphocytes, with forward scatter not seeming to reflect the clearly large size of lymphoid cells seen under the microscope.
A strategy used by others, "back-gating," theoretically overcomes the danger of overlooking lymphocytes with unexpected light scatter. [20] [21] [22] Although there are variations in the method, back-gating generally involves analysis of certain leukocyte antibodies (CD19 or CD20 and CD3, for example) followed by adjusting the lymphocyte region on the initial light scatter histograms to include all cells of interest. 20 Some also use CD45 and CD14 differential staining to exclude nonlymphocytes, followed by backgating to the initial light scatter histograms to guide the search for diagnostic cells. 21, 22 However, a drawback of the back-gating method is that great variation in CD45 staining intensity within the same lymphoma may be seen, in contrast with the predictable, stable, bright CD45 expression by normal lymphocytes on which the technique is based. 22 Such aberrant CD45 expression was observed in our series, with 19% of cases expressing dim CD45, 2% CD45-, and 1 case mixed bright/dim CD45 staining. Back-gating also is most successful when samples are abundantly cellular. In reality, many specimens we receive for analysis are small fragments of biopsy specimens shared with surgical pathology or paucicellular body fluid specimens. Our review of the literature and our case series reveal that no one method is uniformly successful in gating and immunophenotyping large B-cell lymphoma. A higher diagnostic yield is possible with awareness of the range of irregularities in flow cytometric results and various strategies to overcome them.
Our percentage of false-negative cases (4 cases [8%]) approximates that reported by others in the literature for large cell lymphomas. In these cases, a monoclonal population ❚Image 3❚ (Case 29) Apoptotic cells prevalent. This skin biopsy specimen shows aggregates of atypical large lymphocytes with numerous apoptotic cells (shrunken, dark nuclei and dense cytoplasm) (H&E, ×600).
❚Image 4❚ (Case 46) Monoclonal B cells. Atypical large and pleomorphic lymphocytes in a background of sclerosis are seen in this lymph node biopsy specimen (H&E, ×600).
could not be found, even by looking in regions of unexpectedly low forward and high side scatter for the cells and by anticipating abnormal antigen expression, such as dim CD19. Interestingly, 1 of our cases was CD45-. This has been reported before to pose a problem for a surgical pathologist using the immunoperoxidase analog of CD45, LCA (leukocyte common antigen), to rule out lymphoma in a biopsy of a high-grade malignant neoplasm. 23 The flow cytometrist must continue to evaluate for the presence of B cells expressing CD19 and/or CD20 in CD45-cases. A third of our total cases expressed dim CD19, while a small minority expressed dim CD20. CD20 dimness was found to be a statistically significant feature for the complex cases.
Although the threshold values for kappa/lambda ratios to define light chain restriction vary considerably in the literature, light chain restriction remains the primary means of identifying a monoclonal population in B-cell lymphomas, with supporting evidence of other aberrant antigen expression. However, identifying light chain restriction in large B-cell lymphomas has its pitfalls. Gelb et al 24 showed light chain restriction in only 24% of nodal and 25% of extranodal large B-cell lymphomas. Of the cases in our series, 90% (46/51) showed light chain restriction. Technical factors may lead to falsely negative surface kappa or lambda, or the lymphoma cells may have defective transcription or translocation of immunoglobulins to the cell surface, as a result of clonal gene rearrangements. 25 Robins et al 26 noted in a study of flow cytometry used for bone marrow samples that lower intensity measures were seen when either kappa or lambda was coupled to FITC, rather than PE. In our series, 77% of cases with detectable light chain restriction expressed kappa, and in all cases the antibody was coupled to FITC. One case showed kappa expression, but was too dim to accurately calculate a kappa/lambda ratio. If other flow cytometric features are used in concert with kappa and lambda expression to define monoclonality, possible artifactual variation in intensity when using FITC should not pose a large problem. Others have found that comparing histograms of kappa and lambda expression using the same fluorochrome (FITC) conjugated to the antikappa and lambda antisera overcame dim surface immunoglobulin results in interpreting monoclonality. 27 Evaluating cytoplasmic immunoglobulin expression also may reveal or amplify light chain restriction in challenging cases.
Considering that flow cytometric analysis occasionally may be nondiagnostic or results may even conflict with morphologic features as reported by the surgical or cytopathologist, one may question whether flow cytometric analysis is worthwhile in the workup of large B-cell lymphomas. 28 Immunohistochemical analysis often is used in the place of flow cytometric analysis when tissue is received already in formalin, when lymphoma is not initially suspected (for example, no frozen section was requested to reveal the lymphoid nature of a tumor before standard histologic processing), or in the case of a very small sample at the discretion of the pathologist. The range of preserved antigens after tissue processing, however, is limited. 3 In one study, immunoglobulin light chain restriction (monoclonality) was shown in only one third of B-cell lymphomas by immunohistochemical analysis. 29 Fineberg et al 6 showed immunohistochemical analysis performed on bone marrow biopsy specimens to be only moderately reliable in B-cell neoplasms compared with flow cytometric analysis performed on bone marrow aspirates. This information is needed not only for the ❚Figure 4❚ (Case 46) Monoclonal B cells with high side scatter. Light scatter gating showed a heterogeneous population of cells with a lymphocyte component not clearly separable (upper left) . No large cells were clearly identifiable. As seen in the upper right histogram, gated on light scatter and CD19+ cells, monoclonality was detected in the low side scatter population (A gate). Events with high side and forward scatter at the upper right edge of the histogram prompted us to re-collect cell events and plot them using a log scale for side scatter (lower left). This strategy brought into view the large lymphocytes with unusually high side scatter (lower right histogram). Although many of the cells show nonspecific staining (region 2), kappa light chain restriction also is seen among CD19+ cells (region 4). This case demonstrates how sclerosis leads to cell distortion artifact and unexpected side and forward scatter. FITC, fluorescein isothiocyanate; FS, forward scatter; PE, phycoerythrin; SS, side scatter. kappa-FITC Large Cells Scatter Gate diagnosis but also for follow-up by the patients' oncologists, as prognostic immunophenotypic variables continue to be identified. 30, 31 Immunohistochemical results also may be misleading, as positive staining for epithelial membrane antigen and cytokeratin has been reported in rare cases of large B-cell lymphomas. In these same reported cases, stains for CD45 and CD20 were negative, leading to misdiagnoses of carcinoma. 23 Monoclonality detected by flow cytometry may prevent such misdiagnoses, as CD45-cells would routinely be further analyzed for other lymphoid markers, such as CD19 and light chain expression. In addition, flow cytometric analysis has the advantage of testing several antigens at once, without exhausting a small tissue biopsy specimen in a paraffin block with multiple special histochemical stains. Reliance on histochemical stains can consume days before a final diagnosis can be made and appropriate treatment can be initiated.
Flow cytometric data can be critical in hypocellular samples such as peripheral blood and body fluids. 32 In small tissue biopsy specimens, tissue preservation can be poor with crush artifact, especially with the fragile nature of high-grade lymphoid neoplasms. 8 In these cases, flow cytometric analysis again can be very important for establishing the lymphoid nature of the malignant neoplasm and the cell of origin as B or T cell. After a diagnosis is established, flow cytometric data are helpful for detecting residual or recurrent disease and transformation of low-grade to higher-grade lymphoma. 1, 26 Duggan et al 1 concluded that while neither flow cytometric results nor morphologic features should be used alone, flow cytometric analysis was the most sensitive for detecting minimal bone marrow lymphoma, with a falsenegative rate of 17% when the diagnosis was based on morphologic features alone.
A disadvantage of flow cytometric analysis is potential redundancy of information, especially in an era of increased cost-consciousness. Retrospectively, it may appear that in some cases, morphologic examination alone is sufficient to make a diagnosis of large cell lymphoma. One strategy could be holding tissue for possible flow cytometric analysis until after morphologic data are available, with processing of the sample only if requested by the pathologist. In practice, however, tissue is best submitted simultaneously for immunophenotyping and morphologic evaluation. As a sample is stored, cells continue to degenerate. The diagnostic yield and quality of the flow cytometric results is best with the freshest specimens, in our experience. Furthermore, a very small proportion of the specimen may be composed of neoplastic cells, and delaying specimen processing may make interpretation and diagnostic yield of such specimens increasingly difficult. The potential redundancy of flow cytometric analysis also is outweighed by the usefulness of documenting a baseline lymphoma phenotype. For economy, the use of more limited panels, as were performed in this series, including key diagnostic markers and those of proven prognostic significance, ought to be considered. This approach may not be possible in a reference laboratory, with little to no clinical and morphologic information.
Conclusion
Many variables lead to nondiagnostic flow cytometric results in morphologically diagnostic large B-cell lymphomas. Many of these, including inadequate tissue sampling, the flow cytometrist has no control over. However, we have identified and reviewed several ways that a flow cytometrist can evaluate even a suboptimal sample to identify the neoplastic cells and aid in the diagnostic workup of these patients. These tools include various gating strategies, analysis of small and apoptotic cells, evaluation of cytoplasmic immunoglobulin expression, anticipating aberrant antigen expression such as CD45 negativity, and use of a log scale to isolate neoplastic populations. Demographic data, clinical information, and morphologic features of necrosis, apoptosis, pleomorphism, mitotic activity, and sclerosis did not correlate with flow cytometric patterns. Although flow cytometric results occasionally may be nondiagnostic, flow cytometric analysis still has a valuable role in the workup and characterization of large B-cell lymphomas.
